BacteriaFAQ.com

Vancomycin Intermediate-Resistant Staphylococcus aureus (VISA) represents a significant and growing challenge in healthcare settings. As a specific strain of the common Staph bacteria, VISA has developed a troubling level of resistance to vancomycin, an antibiotic traditionally used as a last resort for treating serious methicillin-resistant Staphylococcus aureus (MRSA) infections. This diminished susceptibility makes VISA infections difficult to manage and poses a serious threat to patient safety.

This guide provides a detailed overview of VISA, including where it’s found, the health risks it presents, and most importantly, how to control its spread in clinical environments.

Definition and Overview: What is VISA?

VISA is a strain of Staphylococcus aureus that has mutated to develop an intermediate level of resistance to the glycopeptide antibiotic vancomycin. Unlike Vancomycin-Resistant Staphylococcus aureus (VRSA), which is fully resistant, VISA can still be inhibited by vancomycin, but it requires higher concentrations of the drug than are safely achievable in a patient's bloodstream.

This resistance is typically caused by a thickening of the bacterium's cell wall. The thicker wall acts like a shield, trapping vancomycin molecules and preventing them from reaching their target site to kill the bacterium. This mechanism makes VISA a stubborn and persistent pathogen.

Where It’s Commonly Found

VISA is almost exclusively a healthcare-associated pathogen. It thrives in environments where antibiotic use is high, which creates the selective pressure needed for resistance to develop. Patients who are most at risk of acquiring a VISA infection are those with a history of:

• Prolonged Hospital Stays: Longer exposure to a hospital environment increases the risk of colonization.
• Previous MRSA Infections: Patients who have battled MRSA are more likely to develop VISA if they require long-term vancomycin therapy.
• Chronic Conditions: Individuals with underlying health issues like diabetes, kidney disease (especially those on dialysis), or weakened immune systems are more vulnerable.
• Invasive Medical Devices: The presence of catheters, central lines, or prosthetic devices provides a direct pathway for bacteria to enter the body.

VISA can contaminate high-touch surfaces in patient rooms, on medical equipment, and on the hands of healthcare workers, making environmental hygiene a critical component of infection control.

Health Risks and Transmission

VISA causes the same types of infections as other Staphylococcus aureus strains, but the consequences are often more severe due to treatment limitations. Common infections include:

• Bacteremia (Bloodstream Infections): Can lead to sepsis, a life-threatening condition.
• Endocarditis: A serious infection of the heart valves.
• Pneumonia: Particularly in ventilated patients.
• Osteomyelitis (Bone Infections): Difficult to treat and can become chronic.

The primary mode of transmission is through direct contact. This can happen when a healthcare worker with contaminated hands touches a patient or when a patient comes into contact with a contaminated surface or piece of medical equipment. Because treatment options are limited and often require more toxic alternative antibiotics, VISA infections are associated with higher rates of treatment failure, longer hospital stays, and increased mortality.

How to Kill or Control VISA

Controlling the spread of VISA requires a multi-faceted approach centered on stringent infection control protocols. Since antibiotics are less effective, prevention through environmental disinfection is paramount.

1. Surface Disinfection with EPA-Registered Wipes:
Effective cleaning and disinfection of environmental surfaces are crucial. Use disinfectant wipes that are EPA-registered and have a specific claim for killing Staphylococcus aureus with intermediate resistance to vancomycin (VISA). Pay close attention to the dwell time—the amount of time the surface must remain visibly wet for the disinfectant to work. For VISA, this can be several minutes.

2. Focus on High-Touch Surfaces:
Routinely disinfect bed rails, call buttons, overbed tables, medical monitoring equipment, and doorknobs. Janitorial staff and nurses must be trained to use proper techniques, moving from cleaner areas to dirtier areas to prevent cross-contamination.

3. Strict Hand Hygiene:
Handwashing with soap and water or using an alcohol-based hand sanitizer is the single most important practice. Healthcare providers must perform hand hygiene before and after every patient contact, after touching any surface in the patient’s vicinity, and after removing gloves.

4. Patient Isolation:
Patients diagnosed with a VISA infection are often placed under contact precautions. This involves isolating the patient in a single room and requiring staff and visitors to wear gowns and gloves upon entry.

Who Should Be Concerned?

VISA is a major concern for a specific group of professionals and facility managers:

• Infection Control Practitioners and Healthcare Providers: Doctors, nurses, and specialists are on the front lines of identifying, treating, and preventing the spread of VISA.
• Hospital Administrators and Facility Managers: They are responsible for implementing and enforcing infection control policies, providing necessary supplies like EPA-registered disinfectants, and ensuring staff are properly trained.
• Janitorial and Environmental Services (EVS) Staff: This team plays a critical role in breaking the chain of transmission by properly cleaning and disinfecting patient rooms and common areas. Their diligence is essential for patient safety.
• Dialysis Center Operators: Due to the vulnerability of dialysis patients, these facilities must maintain the highest standards of hygiene to prevent VISA outbreaks.

VISA represents a serious evolution in antibiotic resistance. Because treatment is so challenging, the focus must shift aggressively toward prevention. Rigorous adherence to cleaning protocols, proper use of effective disinfectants, and unwavering commitment to hand hygiene are the most powerful tools available to protect vulnerable patients from this dangerous pathogen.

For maintaining the highest standards of hygiene and controlling pathogens like VISA, we recommend using EPA-registered disinfectant products. Wipes.com offers a range of hospital-grade disinfectant wipes that are proven effective against a broad spectrum of antibiotic-resistant bacteria, helping you protect your patients and staff.